PHILADELPHIA – March 11, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid Read more
Our guest post, “Copay Comes Full Circle – An Industry Ready for Disruption” is featured on Drug Channels, Read more
Paysign is eager to be an exhibition partner at the 7th Annual Gene Therapy for Rare Disorders Summit Read more
Paysign is excited to be a supporting sponsor at the ACCESS USA event, "Accelerating Access, Partnerships and Collaboration Read more